| Dr Matthew Sherwood, DC | |
|
1425 Eagle Ridge Dr, Schererville, IN 46375-1386 | |
| (219) 322-6942 | |
| Not Available |
| Full Name | Dr Matthew Sherwood |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 15 Years |
| Location | 1425 Eagle Ridge Dr, Schererville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710115373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 080027212A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthlinc Inc | 7618929373 | 57 |
News Archive
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company's IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems which can deliver MicroPulse laser treatments.
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
A new study suggests that echocardiography be included as part of screenings to help identify student athletes with heart problems that could lead to sudden death.
› Verified 5 days ago
| Provider Name | Healthlinc Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528262581 PECOS PAC ID: 7618929373 Enrollment ID: O20050210000929 |
News Archive
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company's IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems which can deliver MicroPulse laser treatments.
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
A new study suggests that echocardiography be included as part of screenings to help identify student athletes with heart problems that could lead to sudden death.
› Verified 5 days ago
| Provider Name | Motus Integrative Health Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033611702 PECOS PAC ID: 0547521650 Enrollment ID: O20180307000737 |
News Archive
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company's IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems which can deliver MicroPulse laser treatments.
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
A new study suggests that echocardiography be included as part of screenings to help identify student athletes with heart problems that could lead to sudden death.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Sherwood, DC 1425 Eagle Ridge Dr, Schererville, IN 46375-1386 Ph: (219) 322-6942 | Dr Matthew Sherwood, DC 1425 Eagle Ridge Dr, Schererville, IN 46375-1386 Ph: (219) 322-6942 |
News Archive
IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company's IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems which can deliver MicroPulse laser treatments.
Combining the drug gemtuzumab ozogamicin with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia, according to a study led by St. Jude Children's Research Hospital. The results appear in the current edition of the journal Cancer.
Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.
A new study suggests that echocardiography be included as part of screenings to help identify student athletes with heart problems that could lead to sudden death.
› Verified 5 days ago
Motus Integrative Health Chiropractor Medicare: Medicare Enrolled Practice Location: 1425 Eagle Ridge Dr, Schererville, IN 46375 Phone: 219-322-6942 | |
Deboer Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2433 Ontario St Ste B, Schererville, IN 46375 Phone: 708-895-1798 | |
Northwest Indiana Chiropractic Health Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1425 Eagle Ridge Dr, Schererville, IN 46375 Phone: 219-322-6942 Fax: 219-515-2068 | |
Hayes Family Wellness Center Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11 E Joliet St, Schererville, IN 46375 Phone: 219-661-8680 | |
Tiffany Marie Bozovich, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 221 S Rt 41, Suite B, Schererville, IN 46375 Phone: 219-322-4406 Fax: 219-322-7539 | |
Crowder Family Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 11 E Joliet St, Schererville, IN 46375 Phone: 219-864-8284 Fax: 219-864-8280 | |
Dr. Lana Louise Kaiser, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 322 E Us Highway 30, Schererville, IN 46375 Phone: 219-864-7967 Fax: 219-864-8142 |